Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kiyoshi Mori, H. Thomas Lee, Dana Rapoport, Ian R. Drexler, Kirk Foster, Jun Yang, Kai M. Schmidt-Ott, Xia Chen, Jau Yi Li, Stacey Weiss, Jaya Mishra, Faisal H. Cheema, Glenn Markowitz, Takayoshi Suganami, Kazutomo Sawai, Masashi Mukoyama, Cheryl Kunis, Vivette D’Agati, Prasad Devarajan, Jonathan Barasch
Published in Volume 115, Issue 3
J Clin Invest. 2005; 115(3):610–621 doi:10.1172/JCI23056
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1

Ngal expression in ATN of human (AD) and mouse (E). (A) Monoclonal anti–human Ngal (Mo) and polyclonal anti–mouse Ngal (Po) antibodies recognized recombinant (21-kDa) and native (25-kDa) human and mouse Ngal. Occasionally, higher–molecular weight species (approximately 35 kDa and 66 kDa) were present in recombinant and native preparations; these might represent dimers and trimers of Ngal. A standard curve was constructed with 25, 5, 1, and 0.2 ng recombinant proteins on nonreducing gels. Human urine samples (0.1–20 μl) from patients with ATN showed high levels of Ngal, whereas samples from patients with chronic renal failure (CRF), patients with liver cirrhosis, hemochromatosis, or pancreatic carcinoma but lacking a renal diagnosis (Others), or normal subjects (Normal) had low levels of Ngal. (B) Similar data were obtained from human serum. (C and D) Geometric means (bar ± SD) of urinary (C) and serum (D) Ngal were compared in normal, CRF, and ATN groups. ATN was further divided into sepsis and nonsepsis. *P < 0.05, **P < 0.01, ***P < 0.001 vs. normal. (E) Mouse ATN was also associated with elevated urinary Ngal. The renal pedicle was cross-clamped for 30 minutes, and urine was collected at 24 hours of reperfusion and analyzed by immunoblot (5 μl/lane).